Citation link: http://dx.doi.org/10.25819/ubsi/10247
Files in This Item:
Dokument Type: Article
metadata.dc.title: Self-guided digital treatment with virtual reality for panic disorder and agoraphobia
Title addition: a study protocol for a randomized controlled trial
Authors: Planert, Jari 
Machulska, Alla 
Hildebrand, Anne‑Sophie 
Roesmann (Keuper), Kati 
Otto, Esra 
Klucken, Tim 
Institute: Fakultät V - Lebenswissenschaftliche Fakultät 
Free keywords: Virtual reality, Cognitive behavioral therapy, Agoraphobia, Panic disorder, Self-guided help, Short-term treatment, E-health
Dewey Decimal Classification: 150 Psychologie
GHBS-Clases: HQN
HSG
HVQH
HVRG
Issue Date: 2022
Publish Date: 2023
Source: Trials ; 23, article number 426. - https://doi.org/10.1186/s13063-022-06366-x
Abstract: 
Background
Cognitive behavioral therapy is the first-line treatment for patients with panic disorder (PD) and agoraphobia (AG). Yet, many patients remain untreated due to limited treatment resources. Digital self-guided short-term treatment applications may help to overcome this issue. While some therapeutic applications are already supported by health insurance companies, data on their efficacy is limited. The current study investigates the effect of self-guided digital treatment comprising psychoeducation and virtual reality exposure therapy (VRET).
Methods
Thirty patients diagnosed with PD, AG, or panic disorder with agoraphobia (PDA) will be randomly assigned to either the experimental group (EG) or the control group (CG). Participants of both groups will undergo baseline diagnostics in the first two sessions. The subsequent treatment for the EG consists of a self-guided 6-week phase of application-based psychoeducation, one therapy session preparing for the VRET, and 4 weeks of application-based self-guided VRET. To control for the potential effects of the therapy session with the therapist, the CG will receive relaxation and stress-reduction training instead. All patients will then undergo a closing session which terminates with the post-assessment (~ 10 weeks after baseline assessment) and a follow-up assessment 6 weeks following the closing session. Symptom severity (primary outcome) will be assessed at baseline, interim, post-treatment, and follow-up. Additionally, remission status (secondary outcome) will be obtained at follow-up. Both measures will be compared between the groups.
Discussion
The current study aims at providing insights into the efficacy of short-term treatment applications including psychoeducation and self-guided VRET. If successful, this approach might be a feasible and promising way to ease the burden of PD, AG, and PDA on the public health system and contribute to a faster access to treatment.
Description: 
Finanziert im Rahmen der DEAL-Verträge durch die Universitätsbibliothek Siegen
DOI: http://dx.doi.org/10.25819/ubsi/10247
URN: urn:nbn:de:hbz:467-24416
URI: https://dspace.ub.uni-siegen.de/handle/ubsi/2441
License: http://creativecommons.org/licenses/by/4.0/
Appears in Collections:Publikationen aus der Universität Siegen

This item is protected by original copyright

Show full item record

Page view(s)

37
checked on Feb 8, 2023

Download(s)

25
checked on Feb 8, 2023

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons